Back

Targeted therapies in genetic dilated and hypertrophic cardiomyopathies.

13 June 2023 (09:45 - 10:30)
Organised by: Logo
Seminar Presentation Part of: Novel insights into heart failure Basic Science Delegate Premium access CBCS Summer School 2023 Council on Basic Cardiovascular Science

About the speaker

Photo
Professor Christoph Maack

University Clinic Wuerzburg, Wuerzburg (Germany)

1 More presentation in this session

Presentation thumbnail
Pathophysiology of heart failure: Heart failure with preserved ejection fraction (HFpEF), heart failure with reduced ejection fraction (HFrEF), and everything in between
Associate Professor R. Madonna (Pisa, IT)
Slides

Access the full session

Session thumbnail
Novel insights into heart failure

The Event

Event poster

CBCS Summer School 2023

13 June 2023 09:45 CET
You may be interested in
thumbnail
Congress Session
Implications of obstructive hypertrophic cardiomyopathy (oHCM) for heart failure specialists
17 May 2025
thumbnail
Congress Presentation
Impact of genetic testing on the management in patients with idiopathic dilated cardiomyopathy
30 June 2021
thumbnail
Congress Presentation
Angiotensin II receptor blockers is associated a decreased left ventricular fibrosis in patients with obstructive hypertrophic cardiomyopathy
25 April 2024
thumbnail
Congress Session
New treatment targets for personalised therapy in genetic cardiomyopathies
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources